Immunic, Inc.

About Immunic, Inc.

Immunic Therapeutics is a biotechnology company focused on developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, with a mission to provide high-quality, oral treatment options with comprehensive therapeutic efficacy and outstanding safety for patients, particularly those with multiple sclerosis and celiac disease.

Products & Services

Vidofludimus Calcium:An oral therapy aimed at elevating the standard of care for multiple sclerosis patients with comprehensive therapeutic efficacy and outstanding safety and tolerability.

IMU-856:An oral treatment option for celiac disease patients, designed to be efficacious, safe, and well-tolerated to improve their quality of life by eliminating debilitating symptoms.

IMU-381:An oral small molecule therapy under development for chronic inflammatory and autoimmune diseases, with specific details not provided in the content.

Specialties

Oral small molecule therapies Chronic inflammatory diseases Autoimmune diseases Multiple sclerosis treatment Celiac disease treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 200000000 MR: - FA: USD 200 Million FAN: 200000000	D: 2026-02-17 FD: 2026-02-17	13 investors
2	RT: Private Placement T: - FT: Private Placement	A: 400000000 MR: - FA: up to USD 400 million FAN: 400000000	D: 2026-02-13 FD: 2026-02-13	13 investors
3	RT: Public Offering T: - FT: Public Offering	A: 65000000 MR: - FA: approximately $65 million FAN: 65000000	D: 2025-06-03 FD: 2025-06-03	5 investors
4	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 65000000 MR: - FA: $65 million FAN: 65000000	D: 2025-05-29 FD: 2025-05-29	4 investors
5	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 5100000 MR: - FA: 5.1 million FAN: 5100000	D: 2025-04-10 FD: 2025-04-10	1 investors
6	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 5100000 MR: - FA: approximately $5.1 million FAN: 5100000	D: 2025-04-09 FD: 2025-04-09	1 investors
7	RT: Private Placement T: - FT: Private Placement	A: 240000000 MR: - FA: up to $240 million FAN: 240000000	D: 2024-01-05 FD: 2024-01-05	6 investors

Private Placement Latest

2026-02-17

$200.0M

13 investors (Pro only)

Private Placement 2026-02-13

$400.0M

Public Offering 2025-06-03

$65.0M

View 6 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Immunic, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised